Results 71 to 80 of about 16,637 (150)

Top 5 Advances in the Last 50 Years: Malignant Gastric and Esophageal Surgery

World Journal of Surgery, EarlyView.
Luís Santos Castro, Lorenzo Ferri
wiley   +1 more source

Influence of dietary intake and eating patterns on reactive hypoglycemic events in patients postesophagectomy: A prospective observational study using continuous glucose monitoring

Nutrition in Clinical Practice, Volume 41, Issue 3, Page 880-891, June 2026.
Abstract Background Esophagectomy causes anatomical changes that can lead to rapid food transit and reactive hypoglycemia (RH). Patients are advised on eating patterns postesophagectomy to prevent RH, but its true incidence and the impact of dietary recommendations remain under‐researched.
Rachel O'Kelly, Elaine Quigley, Katie Byrne, Mistura A. Kareem, Niamh Ni Mhaoinigh, Paul Healy, Michelle Fanning, John V. Reynolds, Claire L. Donohoe, Suzanne L. Doyle   +9 more
wiley   +1 more source

Efficacy comparison of transcervical video-assisted mediastinoscopic lymphadenectomy combined with left transthoracic esophagectomy versus right transthoracic esophagectomy for esophageal cancer treatment

World Journal of Surgical Oncology, 2018
Background This study aimed to propose a new surgical strategy, i.e., the transcervical video-assisted mediastinoscopic lymphadenectomy (VAMLA) with esophagectomy via the left transthoracic approach for patients with esophageal cancer (EC), and to ...
Xu Li, Wenxiang Wang, Yong Zhou, Desong Yang, Jie Wu, Baihua Zhang, Zhining Wu, Jinming Tang   +7 more
doaj   +1 more source

Neoadjuvant versus adjuvant chemoradiotherapy for resectable cT3‐4a esophageal squamous cell carcinoma: A matched cohort analysis

Precision Radiation Oncology, Volume 10, Issue 2, Page 155-164, June 2026.
Neoadjuvant chemoradiotherapy (NCRT) significantly improves overall survival over adjuvant chemoradiotherapy for resectable cT3‐4a esophageal squamous cell carcinoma, with comparable progression‐free survival and toxicity. This propensity‐matched study supports NCRT as the preferred strategy for this high‐risk population.
Mingqiang Lin, Yilin Yu, Yibing Hu, Rong Zheng, Jiancheng Li, Qiwei Yao   +5 more
wiley   +1 more source

Revisiting Thoracic Duct Resection in Esophageal Squamous Cell Carcinoma: A Propensity‐Matched Analysis and Immunologic Insight Into Recurrence Risk

Thoracic Cancer, Volume 17, Issue 11, June 2026.
Thoracic duct resection did not improve overall or recurrence‐free survival in esophageal squamous cell carcinoma after McKeown esophagectomy. In node‐negative patients, it was associated with a higher recurrence risk, supporting selective thoracic duct preservation when oncologically feasible.
Xin Zhang, Xin‐Yu Liu, Yu‐Jin Lv, Shi‐Ning Li, Yong Ao, Le‐Qi Zhong, Yi Hu   +6 more
wiley   +1 more source

Thoracic endovascular aortic repair for advanced esophageal cancer invading the aorta: A prognosis analysis among 124 patientsCentral MessagePerspective

JTCVS Open
Objectives: Advanced esophageal cancer invading the aorta is considered an unresectable disease with a poor prognosis. We evaluated the clinical impact of elective thoracic endovascular aortic repair implantation on the prognosis of such patients ...
Hsiao-Hung Lu, MD, Ke-Cheng Chen, MD, PhD, Chih-Yang Chang, MD, PhD, Pei-Ming Huang, MD, PhD, Mong-Wei Lin, MD, PhD, Shuenn-Wen Kuo, MD, PhD, I-Hui Wu, MD, PhD, Jang-Ming Lee, MD, PhD   +7 more
doaj   +1 more source

How to Define the Gastroesophageal Junction

Digestive Endoscopy, Volume 38, Issue 6, June 2026.
ABSTRACT Adenocarcinomas at the gastroesophageal junction (GEJ) are increasingly common worldwide. Current classifications, such as Siewert type II and Nishi, provide a foundation, but establishing a transparent and widely accepted framework could considerably enhance identification and treatment efforts.
Ken‐ichi Mukaisho, Sachiko Kaida, Takahisa Nakayama, Masaji Tani, Michael Vieth, Takanori Hattori, Ryoji Kushima   +6 more
wiley   +1 more source

A Randomized Controlled Phase 3 Trial of Oral Prednisolone Administration Versus Local Triamcinolone Injection Therapy for Esophageal Stricture Prevention After Extensive Endoscopic Submucosal Dissection (JCOG1217)

Digestive Endoscopy, Volume 38, Issue 6, June 2026.
Randomized controlled phase 3 for esophageal stricture prevention after ESD (JCOG1217). ABSTRACT Objectives Endoscopic local triamcinolone injection is a standard therapy for esophageal stricture (ES) prevention after extensive endoscopic submucosal dissection (ESD); however, oral prednisolone administration is a promising alternative. This trial aimed
Masaki Tanaka, Hiroyuki Ono, Kohei Takizawa, Shintaro Iwamoto, Yusuke Sano, Seiichiro Abe, Tomohiro Kadota, Takuya Wada, Akiyoshi Ishiyama, Hiroyoshi Nakanishi, Shinji Nagata, Haruhiko Fukuda, Manabu Muto, Tomonori Yano, the Gastrointestinal Endoscopy Study Group of the Japan Clinical Oncology Group   +14 more
wiley   +1 more source

The Financial Argument for Centralization of Care for Esophagectomy

Annals of Surgery Open
Objective:. To determine if spending is lower at high-volume esophagectomy centers. Background:. There is growing enthusiasm for centralization of care for operations with strong volume-outcome relationships, such as esophagectomy.
Samantha L. Savitch, MD, Cody L. Mullens, MD, Jyothi R. Thumma, MPH, Nicole M. Mott, MD, Kiran H. Lagisetty, MD, Kyle H. Sheetz, MD   +5 more
doaj   +1 more source

Association of hospital volume and operative approach with clinical and financial outcomes of elective esophagectomy in the United States.

PLoS ONE
IntroductionLiterature regarding the impact of esophagectomy approach on hospitalizations costs and short-term outcomes is limited. Moreover, few have examined how institutional MIS experience affects costs.
Saad Mallick, Nikhil L Chervu, Jeffrey Balian, Nicole Charland, Alberto R Valenzuela, Sara Sakowitz, Peyman Benharash   +6 more
doaj   +1 more source